Lehman & Derafelo Financial Resources’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$10.9M Sell
211,824
-1,115
-0.5% -$53.5K 3.22% 6
2022
Q3
$9.32M Sell
212,939
-3,735
-2% -$181K 2.94% 8
2022
Q2
$11.4M Buy
216,674
+1,289
+0.6% +$65.7K 3.51% 6
2022
Q1
$11.2M Buy
215,385
+625
+0.3% +$32.4K 3.1% 8
2021
Q4
$12.7M Sell
214,760
-1,308
-0.6% -$64.8K 3.83% 5
2021
Q3
$9.29M Sell
216,068
-2,360
-1% -$105K 3.02% 7
2021
Q2
$8.55M Buy
218,428
+5,917
+3% +$230K 2.34% 9
2021
Q1
$7.7M Buy
212,511
+7,354
+4% +$261K 2.16% 9
2020
Q4
$7.55M Buy
205,157
+1,695
+0.8% +$62.2K 2.26% 9
2020
Q3
$7.47M Buy
203,462
+14
+0% +$517 2.38% 7
2020
Q2
$6.65M Buy
203,448
+845
+0.4% +$30.3K 2.32% 9
2020
Q1
$6.61M Sell
202,603
-616
-0.3% -$22.1K 2.75% 7
2019
Q4
$7.96M Buy
203,219
+316
+0.2% +$11.9K 2.86% 8
2019
Q3
$7.29M Buy
202,903
+5,718
+3% +$219K 2.79% 7
2019
Q2
$8.66M Buy
197,185
+2,284
+1% +$95.6K 3.53% 6
2019
Q1
$8.28M Sell
194,901
-1,286
-0.7% -$54.3K 3.57% 6
2018
Q4
$8.56M Sell
196,187
-1,157
-0.6% -$50.6K 4.26% 5
2018
Q3
$8.7M Sell
197,344
-3,286
-2% -$133K 4.08% 5
2018
Q2
$7.28M Sell
200,630
-606
-0.3% -$21.8K 3.67% 6
2018
Q1
$7.14M Sell
201,236
-5,557
-3% -$201K 3.66% 6
2017
Q4
$7.49M Sell
206,793
-4,039
-2% -$145K 3.89% 6
2017
Q3
$7.53M Buy
210,832
+2,311
+1% +$78.3K 3.83% 5
2017
Q2
$7.01M Buy
208,521
+1,737
+0.8% +$57.7K 3.95% 5
2017
Q1
$7.07M Buy
206,784
+1,813
+0.9% +$60.2K 3.91% 6
2016
Q4
$6.66M Buy
204,971
+7,709
+4% +$248K 3.79% 7
2016
Q3
$6.68M Buy
197,262
+2,307
+1% +$81.3K 3.86% 5
2016
Q2
$6.86M Buy
194,955
+163
+0.1% +$5.48K 3.45% 5
2016
Q1
$5.77M Buy
194,792
+933
+0.5% +$28.1K 3.08% 7
2015
Q4
$6.26M Buy
193,859
+809
+0.4% +$26.8K 3.37% 5
2015
Q3
$6.06M Buy
193,050
+1,270
+0.7% +$42.9K 3.09% 5
2015
Q2
$6.43M Sell
191,780
-2,144
-1% -$73.6K 3.11% 5
2015
Q1
$6.75M Buy
193,924
+205
+0.1% +$6.87K 3.1% 4
2014
Q4
$6.03M Buy
193,719
+1,806
+0.9% +$54.6K 2.96% 7
2014
Q3
$5.68M Sell
191,913
-97
-0.1% -$2.87K 2.96% 6
2014
Q2
$5.7M Buy
192,010
+56,158
+41% +$1.69M 2.72% 5
2014
Q1
$4.36M Buy
135,852
+2,003
+1% +$62.9K 2.26% 7
2013
Q4
$4.1M Sell
133,849
-1,898
-1% -$58.2K 2.53% 7
2013
Q3
$3.9M Sell
135,747
-497
-0.4% -$14.3K 2.5% 6
2013
Q2
$3.82M Hold
136,244
– – 2.58% 6

Other funds holding PFE

Lehman & Derafelo Financial Resources's PFE Position: Q4 2022 in Review

Lehman & Derafelo Financial Resources reduced its Pfizer (PFE) stake by 0.52% in Q4 2022, selling an estimated $53.5K and leaving 211,824 shares worth $10.9M. The position accounts for 3.22% of the portfolio, ranked #6.

Lehman & Derafelo Financial Resources first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.7M in Q4 2021. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Lehman & Derafelo Financial Resources held 211,824 shares of Pfizer worth $10.9M as of Q4 2022.
  • Lehman & Derafelo Financial Resources sold 1,115 Pfizer shares in Q4 2022, an estimated $53.5K.
  • Pfizer made up 3.22% of Lehman & Derafelo Financial Resources's portfolio in Q4 2022, its #6 holding.
  • Lehman & Derafelo Financial Resources first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
  • Lehman & Derafelo Financial Resources's Pfizer position peaked at $12.7M in Q4 2021.
  • 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.